Novo Nordisk Partners With JDRF In Type 1 Diabetes Push
This article was originally published in The Pink Sheet Daily
Executive Summary
Novo Nordisk will conduct early research around the underlying autoimmune process central to type 1 diabetes in a partnership with JDRF; the company simultaneously opened its Type 1 Diabetes R&D Center in Seattle.